Hunter discussed some of CareOregon’s behavioral healthcare efforts, singling out for mention the CHAT [Community Health, Assess and Treat] program that dispatches technicians instead of a firetruck ...

Although CareOregon has laid off staff recently, Trump administration policies have resulted in hiring in some areas of the organization, says Eric C. Hunter, president and CEO of ...

The end of continuous enrollment in Medicaid programs in 2023 has resulted in a 19% decrease in the number of people covered by Medicaid nationwide, from 94.3 million in March 2023 to 76 million in ...

Although results are from just the early stages, shorter hospitals and more “one-stop-shop” resolution of clinical issues show that the value-based practices implemented at Risant Health are working, ...

A cohort of 903 perimenopausal women completed validated questionnaires assessing loneliness, objective social isolation, and subjective cognitive function, enabling separation of emotional ...

Smile Digital Health’s Intelligence Hub operationalizes computable clinical knowledge into measurable outcomes. Learn how payers and providers use unified data, digital HEDIS, and guideline-driven ...

Evidence synthesis across randomized comparisons showed limited magnitude and duration of opioid analgesia for most acute pain presentations, challenging assumptions of broad short-term efficacy.

As Smile Digital Health enters its 10th year, CEO Duncan Weatherston shares why 2026 marks a strategic shift from data interoperability to unified data and intelligence. Discover how Smile Omni ...

Fiscal stress reflects rates lagging medical trend; behavioral health utilization far exceeded assumptions (30% vs 3.5%–4%), contributing to consecutive multi–$100M losses and projected 2026 deficits.

Providers may not always like the amounts, but when it comes to standard medical care, CareOregon is on familiar turf. “The core benefits, doctors and hospitals, and all that t ...

BTK inhibitor monotherapy is foundational across several B-cell malignancies, with newer, more selective agents designed to preserve efficacy while improving tolerability relative to first-in-class ...

Jaewon Ryu, M.D., J.D., sees prevention and early recognition of disease as central to value-based care practices and ...